Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Asensus Surgical Inc logo

Asensus Surgical Inc

Sector: Manufacturing   

Industry: Surgical and Medical Instrument Manufacturing

0.26
 
USD
  
0.00
  
(-0.57%)
Optionable: Yes  Market Cap: 76 M  90-day average vol: 1,565,758

Previous close: 0.2615  Open: 0.28  Bid: 0.2601  Ask: 0.269
52 week range    
0.20   
   0.65
Peers   
NUVA / 
NVCN-CA / 
NURO / 
Last updated: Monday 20th May 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

NUMD

0 B-1.50.03

NURO

0 B-114.51

NUVA

3 B-10449.37

NVCN-CA

Financials

ASXC Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccretionOnPreferredStock-40000.0299000.0
AccruedPreferredStockDividends412000.0
Amortization of intangibles-500000.0503000.02 M7 M8 M11 M10 M11 M11 M8 M
Basic EPS from continuing operations-8.69-0.85-0.28-0.32
Basic EPS total-8.69-0.85-0.28-0.32
Basic weighted shares outstanding5 M5 M6 M9 M11 M16 M18 M71 M227 M236 M
Cost of sales-5 M-1 M-1 M-7 M-16 M21 M5 M11 M11 M
Depreciation-983000.0-807000.0-1 M-2 M-2 M-2 M2 M3 M3 M3 M
Depreciation unreconciled503000.02 M7 M8 M11 M10 M11 M11 M8 M
DepreciationAndAmortization-983000.0503000.02 M7 M8 M11 M10 M11 M11 M8 M
Diluted EPS total-5.85-8.32-7.67-13.91-12.61-3.9-8.69-0.85-0.28-0.32
Diluted weighted shares outstanding5 M5 M6 M9 M11 M16 M18 M71 M227 M236 M
GainOnSaleOfPPE-450000.016 M
GeneralAndAdministrativeExpense4 M6 M8 M11 M12 M14 M19 M14 M19 M20 M
Gross operating profit-3 M-694000.0450000.0384000.08 M-12 M-2 M-3 M-4 M
ImpairmentOfCapitalAssets450000.062 M87 M
Income before tax-28 M-38 M-48 M-126 M-148 M-65 M-157 M-61 M-62 M-75 M
Income restructuring and M&A3 M7 M851000.0
Income taxes-392000.0-1 M-6 M-3 M-3 M-3 M-2 M225000.0318000.0
Interest income-2 M-2 M308000.01 M582000.035000.0590000.01 M
InterestExpenseNonOperating954000.01 M2 M2 M2 M4 M5 M19000.0370000.0410000.0
MiscOtherSpecialCharges-2 M35000.0-84 M-13 M1 M-455000.02 M-295000.0
Net income from total operations-28 M-38 M-47 M-120 M-145 M-62 M-154 M-59 M-62 M-76 M
NetIncomeCommonStockholders-28 M-38 M-47 M-120 M-145 M-62 M-154 M-60 M-62 M-76 M
NetIncomeContinuousOperations-28 M-38 M-47 M-120 M-145 M-62 M-154 M-59 M-62 M-76 M
NetNonOperatingInterestIncomeExpense-954000.0-1 M-2 M-2 M-2 M-3 M-4 M16000.0220000.0731000.0
NonRecurringOperationExpense-30000.0
Normalized income-51 M-59 M
Operating income-22 M-37 M-42 M-62 M-62 M-49 M-155 M-60 M-65 M-76 M
Operating income before depreciation (EBITDA)-26 M-35 M-43 M-115 M-135 M-47 M-139 M-47 M-47 M-63 M
OperatingExpense-27 M-37 M-46 M-124 M60 M72 M142 M58 M62 M72 M
Other income net5 M4 M-35000.084 M14 M-27 M3 M-4 M611000.0
OtherGandA4 M6 M8 M11 M12 M14 M19 M14 M19 M20 M
OtherImpairmentOfCapitalAssets-449853.0-1000000.01 M
OtherOperatingExpenses-55000.0-35 M-40 M-50 M-52 M-161000.0-1 M-851000.0-141000.0-194000.0
OtherTaxes-400000.04 M3 M
OtherunderPreferredStockDividend-40000.0711000.0
PreferredStockDividends-40000.0711000.0
RealizedCapitalGain11 M
RentAndLandingFees4 M6 M8 M11 M12 M14 M
Research & development expense13 M28 M30 M29 M22 M22 M22 M17 M19 M29 M
ResearchExpense13 M28 M30 M29 M22 M22 M22 M17 M19 M29 M
RestructringAndMnAIncome3 M7 M851000.0
Revenue per share-565000.0503000.02 M7 M8 M11 M10 M11 M11 M8 M
SalariesAndWages-941000.0-2 M-3 M-5 M-7 M-9 M12 M
Selling Gen & administrative expense6 M7 M11 M20 M30 M40 M47 M27 M33 M35 M
SellingAndMarketingExpense2 M2 M3 M9 M18 M26 M28 M13 M13 M15 M
SellingExpense2 M2 M3 M9 M18 M26 M
Special income/charges-450000.030000.0-62 M-87 M-851000.0
Total Income available for interest expense (EBIT)-27 M-37 M-46 M-124 M-146 M-61 M-153 M-61 M-62 M-75 M
Total common shares outstanding5 M5 M8 M9 M15 M17 M46 M233 M236 M239 M
Total net income-28 M-38 M-47 M-120 M-145 M-62 M-154 M-59 M-62 M-76 M
Total ordinary shares264 M264 M264 M264 M264 M264 M264 M264 M264 M264 M
Total revenues1 M401000.02 M7 M24 M9 M3 M8 M7 M
TotalExpenses-32 M-38 M-46 M-125 M53 M56 M163 M64 M73 M83 M
TotalRevenue1 M401000.02 M7 M24 M9 M3 M8 M7 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University